Core Viewpoint - The company, Brainstorm Aurora-B (06681), has seen its stock price increase by over 4%, currently trading at 4.83 HKD with a transaction volume of 48.71 million HKD, following the announcement of a strategic partnership with Macau Kiang Wu Hospital to enhance digital health services for cognitive disorders [1] Group 1 - The company’s subsidiary, Brainstorm Aurora Medical Technology (Macau) Limited, has signed a cooperation agreement with Macau Kiang Wu Hospital to provide digital AI technology services for brain health [1] - The partnership aims to establish a comprehensive health management model covering "hospital-community-home" for cognitive disorder screening, assessment, training, and management in the Macau region [1] - The board believes this collaboration sets a benchmark for the group and opens up the Greater Bay Area market, marking the first flagship project for the group’s digital therapy in the Hong Kong-Macau region [1] Group 2 - The collaboration enriches the company's ecosystem alliance with authoritative medical institutions, complementing a recent national-level project partnership with the National Rehabilitation Aids Research Center under the Ministry of Civil Affairs [1] - This initiative aims to promote the standardization and large-scale application of cognitive digital therapies [1]

Core Insights - The "Guarding Brain Age" brain health promotion public welfare project has been launched, focusing on the urgent need for brain health among the elderly population [1] - The project aims to provide comprehensive services from early cognitive screening to personalized interventions, helping to reduce the risk of cognitive impairment and improve brain health literacy [1] Group 1: Target Population and Risk Factors - The project targets elderly individuals aged 55 and above who are assessed to be at risk of cognitive decline [1] - High-risk factors include chronic cardiovascular diseases such as hypertension, diabetes, and hyperlipidemia, subjective cognitive decline (SCD), history of stroke or heart disease, family history of Alzheimer's or other dementias, and post-operative cognitive decline (POCD) or delirium (POD) risks [1] Group 2: Services Offered - Participants will receive 30 days of digital cognitive training using personalized plans based on AI algorithms, focusing on core cognitive domains like memory and attention [2] - Comprehensive online clinical intervention services will be provided, with one-on-one follow-up from qualified trainers based on individual brain health assessments [2] - Free biomarker testing will be included, offering a urine β-amyloid protein test to assess the accumulation of brain plaque markers [2] Group 3: Project Timeline and Methodology - The project will run from October 17, 2025, to April 16, 2026, lasting a total of six months [3] - Digital therapy is defined as software-driven interventions based on evidence-based medicine, applicable for preventing, treating, or managing diseases [3] - Cognitive digital therapy is an innovative application in the field of cognitive impairment, validated by research to effectively enhance core cognitive functions through targeted task design [3]

Core Viewpoint - Tencent's cognitive training software "Tencent Brain Exercise" has received medical device registration approval from the Guangdong Provincial Drug Administration, marking its entry into clinical application for improving cognitive abilities in patients with mild cognitive impairment (MCI) [1][3] Industry Overview - The cognitive digital therapy market in China has over 40 companies focusing on this area, with 47 cognitive digital therapy software products approved by the National Medical Products Administration as of October 2024 [2] - The market for cognitive impairment digital therapy is expected to grow significantly, with a projected market size of 2.686 billion yuan in 2023, increasing to 10.467 billion yuan by 2025 and 89.274 billion yuan by 2030, reflecting compound annual growth rates of 97.4% and 53.5% respectively [4] - The number of MCI patients in China is approximately 38.77 million, with a prevalence rate of 15.5%, indicating a substantial patient base driving demand for cognitive digital therapies [4] Company Insights - Tencent's "Tencent Brain Exercise" transforms traditional cognitive rehabilitation into a mobile application format, utilizing gamified cognitive training based on evidence-based medicine principles [3] - The company aims to address the challenges of commercializing digital therapies, as the current business models are still in the early stages of development [1][2] - Brain Dynamics, a competitor in the market, has achieved a market share of 25.0% in the cognitive digital therapy market and 91.6% in the medical-grade cognitive digital therapy market in China, but faces challenges in profitability despite significant revenue growth [5] Challenges in the Market - The cognitive digital therapy sector is experiencing high market education costs and is still in the exploratory phase regarding application scenarios [1][2] - Regulatory challenges exist, as clinical experts have varying opinions on the clinical use of digital therapy products, which complicates their appropriate application [4][5] - The industry faces difficulties in ensuring that payers (such as insurance companies and hospitals) are willing to cover these therapies, which is crucial for sustainable business models [1][2] Competitive Landscape - Major tech companies like Tencent, Alibaba, and ByteDance are entering the healthcare sector, but a mature commercialization model is still needed [6] - The cognitive digital therapy market is characterized by a mix of substantial patient demand and ongoing challenges in commercialization pathways, creating a complex development landscape [2][4]